Kahn Brothers Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Sell |
464,001
-20,732
| -4% | -$542K | 1.77% | 15 |
|
|
2026
Q1 | $13.6M | Sell |
484,733
-69,217
| -12% | -$1.84M | 2.41% | 14 |
|
|
2025
Q4 | $13.8M | Sell |
553,950
-153,194
| -22% | -$3.86M | 2.44% | 11 |
|
|
2025
Q3 | $18M | Sell |
707,144
-23,845
| -3% | -$589K | 3.39% | 11 |
|
|
2025
Q2 | $17.7M | Sell |
730,989
-4,200
| -0.6% | -$97.9K | 3.56% | 12 |
|
|
2025
Q1 | $18.6M | Sell |
735,189
-25,901
| -3% | -$678K | 3.77% | 12 |
|
|
2024
Q4 | $20.2M | Sell |
761,090
-235,935
| -24% | -$6.4M | 4.39% | 12 |
|
|
2024
Q3 | $28.9M | Sell |
997,025
-5,405
| -0.5% | -$158K | 4.97% | 10 |
|
|
2024
Q2 | $28M | Sell |
1,002,430
-20,289
| -2% | -$559K | 4.71% | 11 |
|
|
2024
Q1 | $28.4M | Sell |
1,022,719
-2,962
| -0.3% | -$82.2K | 4.21% | 10 |
|
|
2023
Q4 | $29.5M | Sell |
1,025,681
-30,078
| -3% | -$909K | 4.65% | 12 |
|
|
2023
Q3 | $35M | Sell |
1,055,759
-10,332
| -1% | -$365K | 5.46% | 10 |
|
|
2023
Q2 | $39.1M | Buy |
1,066,091
+36,429
| +4% | +$1.42M | 5.73% | 10 |
|
|
2023
Q1 | $42M | Sell |
1,029,662
-8,644
| -0.8% | -$373K | 6.05% | 10 |
|
|
2022
Q4 | $53.2M | Sell |
1,038,306
-4,047
| -0.4% | -$194K | 7% | 7 |
|
|
2022
Q3 | $45.6M | Sell |
1,042,353
-5,146
| -0.5% | -$250K | 7.11% | 8 |
|
|
2022
Q2 | $54.9M | Buy |
1,047,499
+5,517
| +0.5% | +$281K | 7.39% | 8 |
|
|
2022
Q1 | $53.9M | Buy |
1,041,982
+24,054
| +2% | +$1.25M | 6.85% | 8 |
|
|
2021
Q4 | $60.1M | Buy |
1,017,928
+36,940
| +4% | +$1.83M | 8.26% | 4 |
|
|
2021
Q3 | $42.2M | Buy |
980,988
+156,484
| +19% | +$6.93M | 5.94% | 10 |
|
|
2021
Q2 | $32.3M | Buy |
824,504
+162,217
| +24% | +$6.31M | 4.62% | 11 |
|
|
2021
Q1 | $24M | Sell |
662,287
-12,431
| -2% | -$441K | 3.71% | 12 |
|
|
2020
Q4 | $24.8M | Sell |
674,718
-55,223
| -8% | -$2.03M | 4.33% | 13 |
|
|
2020
Q3 | $25.4M | Sell |
729,941
-75,859
| -9% | -$2.66M | 4.82% | 11 |
|
|
2020
Q2 | $25M | Sell |
805,800
-6,113
| -0.8% | -$208K | 4.22% | 11 |
|
|
2020
Q1 | $25.1M | Sell |
811,913
-41,599
| -5% | -$1.42M | 4.6% | 10 |
|
|
2019
Q4 | $31.7M | Sell |
853,512
-2,111
| -0.2% | -$75.2K | 3.85% | 11 |
|
|
2019
Q3 | $29.2M | Buy |
855,623
+6,082
| +0.7% | +$221K | 3.66% | 11 |
|
|
2019
Q2 | $34.9M | Buy |
849,541
+287,138
| +51% | +$11.4M | 4.37% | 11 |
|
|
2019
Q1 | $22.7M | Sell |
562,403
-864
| -0.2% | -$34.6K | 3.54% | 12 |
|
|
2018
Q4 | $23.3M | Sell |
563,267
-3,057
| -0.5% | -$127K | 4.21% | 11 |
|
|
2018
Q3 | $23.7M | Sell |
566,324
-10,179
| -2% | -$392K | 3.64% | 12 |
|
|
2018
Q2 | $19.8M | Sell |
576,503
-3,138
| -0.5% | -$107K | 3.16% | 15 |
|
|
2018
Q1 | $19.5M | Sell |
579,641
-4,914
| -0.8% | -$169K | 3.11% | 15 |
|
|
2017
Q4 | $20.1M | Sell |
584,555
-3,045
| -0.5% | -$104K | 3.16% | 16 |
|
|
2017
Q3 | $19.9M | Sell |
587,600
-21,207
| -3% | -$682K | 3.04% | 15 |
|
|
2017
Q2 | $19.4M | Sell |
608,807
-94,878
| -13% | -$2.99M | 2.96% | 14 |
|
|
2017
Q1 | $22.8M | Sell |
703,685
-203,061
| -22% | -$6.4M | 3.93% | 11 |
|
|
2016
Q4 | $27.9M | Sell |
906,746
-62,678
| -6% | -$1.91M | 4.72% | 11 |
|
|
2016
Q3 | $31.2M | Sell |
969,424
-249,913
| -20% | -$8.36M | 5.64% | 9 |
|
|
2016
Q2 | $40.7M | Sell |
1,219,337
-301,103
| -20% | -$9.61M | 7.89% | 6 |
|
|
2016
Q1 | $42.8M | Sell |
1,520,440
-134,206
| -8% | -$3.83M | 8.01% | 6 |
|
|
2015
Q4 | $50.7M | Sell |
1,654,646
-106,629
| -6% | -$3.35M | 9.05% | 5 |
|
|
2015
Q3 | $52.5M | Sell |
1,761,275
-109,443
| -6% | -$3.51M | 9.72% | 3 |
|
|
2015
Q2 | $59.5M | Sell |
1,870,718
-38,093
| -2% | -$1.24M | 10.03% | 2 |
|
|
2015
Q1 | $63M | Sell |
1,908,811
-76,100
| -4% | -$2.42M | 10.64% | 1 |
|
|
2014
Q4 | $58.7M | Sell |
1,984,911
-107,449
| -5% | -$3.08M | 10.11% | 3 |
|
|
2014
Q3 | $58.7M | Sell |
2,092,360
-146,851
| -7% | -$4.12M | 9.55% | 3 |
|
|
2014
Q2 | $62.2M | Buy |
2,239,211
+12,300
| +0.6% | +$351K | 9.04% | 4 |
|
|
2014
Q1 | $67.9M | Buy |
2,226,911
+224,565
| +11% | +$6.7M | 9.69% | 2 |
|
|
2013
Q4 | $58.2M | Sell |
2,002,346
-641,088
| -24% | -$18.7M | 10.01% | 2 |
|
|
2013
Q3 | $72M | Sell |
2,643,434
-35,436
| -1% | -$964K | 10.48% | 1 |
|
|
2013
Q2 | $71.2M | Buy |
+2,678,870
| New | +$74M | 10.99% | 1 |
|
Other funds holding PFE
Kahn Brothers Group's PFE Position: Q2 2026 in Review
Kahn Brothers Group reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $542K and leaving 464,001 shares worth $11.2M. The position accounts for 1.77% of the portfolio, ranked #15.
Kahn Brothers Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $72M in Q3 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Kahn Brothers Group held 464,001 shares of Pfizer worth $11.2M as of Q2 2026.
- Kahn Brothers Group sold 20,732 Pfizer shares in Q2 2026, an estimated $542K.
- Pfizer made up 1.77% of Kahn Brothers Group's portfolio in Q2 2026, its #15 holding.
- Kahn Brothers Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Kahn Brothers Group's Pfizer position peaked at $72M in Q3 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Kahn Brothers Group's 13F filing for Q2 2026, filed 14 Aug 2026.